AccuPower® hrHPV Genotyping & Screening Kit

The AccuPower® hrHPV Genotyping & Screening kit is an in vitro diagnostic kit designed for the simultaneous detection of 14 High-risk Human papillomavirus (hrHPV) DNA(16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) from human Cervical swab and liquid based cytology specimen through Real-Time polymerase chain reaction (PCR).
Inquire
Cat. No.
HHP-1111

Product Description

The global incidence and death rates of cervical cancer rank the second and third highest respectively among women. It adds 4,000 ~ 5,000 new cases every year and the incidence rates in young women are increasing. The main cause of cervical cancer is Human papillomavirus (HPV) that infects cervix. The normal cells lining the cervix gradually change to pre-cancerous cells and then turn into cancer by certain virus-producing proteins. The pre-cancerous transformation as a precursor of cervical cancer is referred to as cervical intraepithelial neoplasia (CIN), squamous intraepithelial lesion (SIL), or dysplasia. There are two main types of cervical cancers depending on the cancer location in the cervix: squamous cell carcinoma that occurs in the extocervix and adenocarcinoma in the endocervix.
Today, more than 200 HPV genotypes have been defined, among which 50 can infect the cervical epithelia. high risk (hrHPVs) and 14 show strong evidence of a causal link to cervical cancer. Molecular tests for HPV detection may be a good alternative to cytology for early screening because an HPV-negative result is sufficient to declare an extremely low risk of developing CIN3 or worse (CIN3+) for 5 years in contrast to a negative cytology result.

Features and Benefits

  1. Signature Convenience : Multiplex detection of High-risk Human papillomavirus.
  2. Enhanced Sensitivity & Specificity : Bioneer’s proprietary HotStart™ technology accomplishes high sensitivity and specificity.
  3. Remarkable Stability : Vacuum-dried premix allows stable and reproducible results.
  4. High Quality: All diagnostic kits manufactured by Bioneer are under strict quality control guidelines.

Specifications

 kit AccuPower® hrHPV Genotyping & Screening Kit
target High-risk Human papillomavirus
  Sample Type Cervical swab
  component PCR premix, PC, NTC, DEPC D.W., Optical sealing film150 ul
Instrumentation ExiStation™, Exicycler™ 96

Experimental Data

hrHPV_Fig1_2.png

AccuPower® hrHPV Genotyping & Screening kit includes Positive Control (PC), No Template Control (NTC) for accurate and reliable diagnosis of High-risk Human papillomavirus.

 hrHPV_Fig3

AccuPower® hrHPV Genotyping & Screening kit test results using clinical samples. The kit employs IPC in all wells to confirm correct PCR amplification.

Ordering Information

Cat. No. Product Description
HHP-1111  AccuPower®hrHPV Genotyping & Screening Kit (48 tests)

Related Products

Cat. No. Instrument
A-2060  Exicycler™96 Real-Time Quantitative Thermal Block
A-2060-1
A-2200  ExiStation™Universal Molecular Diagnostic System
A-2200-N
A-5050  ExiPrep™16Dx
A-5150  ExiPrep™48Dx
A-5250  Exiprep96 Lite
Cat. No. Nucleic Acid Extraction Kit
K-4471  ExiPrep™Dx Viral DNA/RNA Kit (96 tests)
K-4472  ExiPre™ Dx Viral DNA Kit (96 tests)
K-4571  ExiPrep™ 48 Viral DNA/RNA Kit (96 tests)
K-4611  ExiPrep™96 genomic DNA kit (384 tests)

Quality Assurance

Bioneer is the holder of Quality Management System Certificates for the following standards.

ISO 13485 - certificate

Contact Us

E-mail : sales@bioneer.com

Copyright© 2020 BIONEER CORPORATION. All rights reserved.